SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE 13G
(Rule 13d-102)
INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT TO RULES
13d-1(b)(c), AND (d) AND AMENDMENTS THERETO FILED PURSUANT TO RULE 13d-2(b)
(Amendment No. 3)*
Cel Sci Corporation
--------------------------------------------------------------------------------
(Name of Issuer)
Common Stock, $.01 par value per share
--------------------------------------------------------------------------------
(Title of Class of Securities)
150837 40 9
--------------
(CUSIP Number)
December 31, 2001
--------------------------------------------------------------------------------
(Date of Event Which Requires Filing of this Statement)
Check the appropriate box to designate the rule pursuant to which this Schedule
is filed:
[ ] Rule 13d-1(b)
[X] Rule 13d-1(c)
[ ] Rule 13d-1(d)
*The remainder of this cover page shall be filled out for a reporting person's
initial filing on this form with respect to the subject class of securities, and
for any subsequent amendment containing information which would alter the
disclosures provided in a prior cover page.
The information required in the remainder of this cover page shall not be deemed
to be "filed" for the purpose of Section 18 of the Securities Exchange Act of
1934 or otherwise subject to the liabilities of that section of the Act but
shall be subject to all other provisions of the Act (however, see the Notes).
Page 1 of 10
-----------------------------------------------------------------------------
1 NAMES OF REPORTING PERSONS
I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (Entities Only)
Advantage Fund II Ltd.
-----------------------------------------------------------------------------
2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP* (a) [ ]
(b) [ ] (See Item 6)
-----------------------------------------------------------------------------
3 SEC USE ONLY
-----------------------------------------------------------------------------
4 CITIZENSHIP OR PLACE OF ORGANIZATION
British Virgin Islands
-----------------------------------------------------------------------------
NUMBER OF 5 SOLE VOTING POWER
SHARES -0-
--------------------------------------------------------------
BENEFICIALLY 6 SHARED VOTING POWER
OWNED BY 2,332,099 shares of Common Stock
--------------------------------------------------------------
EACH 7 SOLE DISPOSITIVE POWER
REPORTING -0-
--------------------------------------------------------------
PERSON 8 SHARED DISPOSITIVE POWER
WITH 2,332,099 shares of Common Stock
-----------------------------------------------------------------------------
9 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
2,332,099 shares of Common Stock
-----------------------------------------------------------------------------
10 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES*
[X]
-----------------------------------------------------------------------------
11 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)
9.99%
-----------------------------------------------------------------------------
12 TYPE OF REPORTING PERSON*
CO
-----------------------------------------------------------------------------
* SEE INSTRUCTIONS BEFORE FILLING OUT!
Page 2 of 10
-----------------------------------------------------------------------------
1 NAMES OF REPORTING PERSONS
I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (Entities Only)
Genesee International, Inc.
-----------------------------------------------------------------------------
2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP* (a) [ ]
(b) [ ] (See Item 6)
-----------------------------------------------------------------------------
3 SEC USE ONLY
-----------------------------------------------------------------------------
4 CITIZENSHIP OR PLACE OF ORGANIZATION
Delaware
-----------------------------------------------------------------------------
NUMBER OF 5 SOLE VOTING POWER
SHARES -0-
--------------------------------------------------------------
BENEFICIALLY 6 SHARED VOTING POWER
OWNED BY 2,332,099 shares of Common Stock
--------------------------------------------------------------
EACH 7 SOLE DISPOSITIVE POWER
REPORTING -0-
--------------------------------------------------------------
PERSON 8 SHARED DISPOSITIVE POWER
WITH 2,332,099 shares of Common Stock
-----------------------------------------------------------------------------
9 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
2,332,099 shares of Common Stock
-----------------------------------------------------------------------------
10 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES*
[X]
-----------------------------------------------------------------------------
11 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)
9.99%
-----------------------------------------------------------------------------
12 TYPE OF REPORTING PERSON*
CO
-----------------------------------------------------------------------------
Page 3 of 10
-----------------------------------------------------------------------------
1 NAMES OF REPORTING PERSONS
I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (Entities Only)
Donald R. Morken
-----------------------------------------------------------------------------
2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP* (a) [ ]
(b) [ ] (See Item 6)
-----------------------------------------------------------------------------
3 SEC USE ONLY
-----------------------------------------------------------------------------
4 CITIZENSHIP OR PLACE OF ORGANIZATION
United States of America
-----------------------------------------------------------------------------
NUMBER OF 5 SOLE VOTING POWER
SHARES -0-
--------------------------------------------------------------
BENEFICIALLY 6 SHARED VOTING POWER
OWNED BY 2,332,099 shares of Common Stock
--------------------------------------------------------------
EACH 7 SOLE DISPOSITIVE POWER
REPORTING -0-
--------------------------------------------------------------
PERSON 8 SHARED DISPOSITIVE POWER
WITH 2,332,099 shares of Common Stock
-----------------------------------------------------------------------------
9 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
2,332,099 shares of Common Stock
-----------------------------------------------------------------------------
10 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES*
[X]
-----------------------------------------------------------------------------
11 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)
9.99%
-----------------------------------------------------------------------------
12 TYPE OF REPORTING PERSON*
IN
-----------------------------------------------------------------------------
Page 4 of 10
Item 1(a). Name of Issuer:
Cel Sci Corporation (the "Corporation").
Item 1(b). Address of Issuer's Principal Executive Offices:
8229 Boone Boulevard, Suite 802, Vienna, Virginia 22182.
Item 2(a). Name of Person Filing:
Advantage Fund II Ltd. ("Advantage")
Genesee International, Inc. ("Genesee")
Donald R. Morken ("Morken")
(collectively, the "Reporting Person")
Item 2(b). Address of Principal Business Office or, if None, Residence:
Advantage - C/O CITCO, Kaya Flamboyan 9, Curacao, Netherlands
Antilles.
Genesee - CITCO Building, Wickhams Cay, P.O.Box 662, Road Town,
Tortola, British Virgin Islands.
Morken - 10500 N.E. 8th Street, Suite 1920, Bellevue, Washington
98004-4332.
Item 2(c). Citizenship:
Advantage - British Virgin Islands.
Genesee - Delaware.
Morken - United States of America.
Item 2(d). Title of Class of Securities:
Common Stock, par value $.01 per share of the Company (the "Common
Stock").
Item 2(e). CUSIP Number:
150837 40 9
Item 3. If This Statement Is Filed Pursuant to Rules 13d-1(b), or 13d-2(b) or
(c), Check Whether the Person Filing is a:
(a) Broker or dealer registered under Section 15 of the Exchange Act;
(b) Bank as defined in Section 3(a)(6) of the Exchange Act;
(c) Insurance company as defined in Section 3(a)(19) of the Exchange
Act;
(d) Investment company registered under Section 8 of the Investment
Company Act;
(e) An investment advisor in accordance with Rule 13d-1(b)(1)(ii)(E);
(f) An employee benefit plan or endowment fund in accordance with
Rule 13d-1(b)(1)(ii)(F);
(g) A parent holding company or control person in accordance with
Rule 13d-1(b)(1)(ii)(G);
(h) A savings association as defined in Section 3(b) of the Federal
Deposit Insurance Act;
(i) A church plan that is excluded from the definition of an
investment company under Section 3(c)(14) of the Investment Company
Act;
(j) Group, in accordance with Rule 13d-1(b)(1)(ii)(J).
If this statement is filed pursuant to Rule 13d-1(c), check this
box. [X]
Item 4. Ownership by Reporting Person.
Provide the following information regarding the aggregate number and
percentages of securities of the issuer identified in Item 1.
Page 5 of 10
(a) Amount beneficially owned:
2,332,099 shares of Common Stock*
(b) Percent of class:
9.99% (based on 23,344,342 shares of Common Stock outstanding as of
December 20, 2001 as reported in the Company's Form10-K filed by
the Company on December 31, 2001).
(c) Number of shares to which such person has:
(i) Sole power to vote or direct the vote:
-0-
(ii) Shared power to vote or direct the vote:
2,332,099 shares of Common Stock*
(iii) Sole power to dispose or to direct the disposition of:
-0-
(iv) Shared power to dispose or direct the disposition of:
2,332,099 shares of Common Stock*
Item 5. Ownership of Five Percent or Less of a Class.
Not Applicable
Item 6. Ownership of More than Five Percent on Behalf of Another Person.
Pursuant to an investment management agreement between Genesee and
Advantage, Genesee has the power to sell or vote on behalf of
Advantage, some or all of the shares of Common Stock to which this
report relates. As such, under Rule 13d-3(a), Genesee may be deemed to
be the beneficial owner of such shares.
Morken is the President of Genesee and has the power to sell or vote
on behalf of Genesee and Advantage, some or all of the shares of
Common Stock to which this report
_____________________
* Does not include certain shares of Common Stock issuable to the Reporting
Person upon: (i) conversion of certain shares of preferred stock issued to the
Reporting Person by the Company and (ii) exercise of certain common stock
purchase warrants issued to the Reporting Person by the Company. The holder of
such shares of preferred stock and common stock purchase warrants is prohibited
from converting or exercising such securities for shares of Common Stock to the
extent that such conversion or exercise would result in such holder, together
with any affiliate thereof, beneficially owning in excess of 9.99% of the
outstanding shares of Common Stock following such conversion or exercise. This
restriction may be waived by the holder of such securities on not less than 61
days' notice to the Company.
Page 6 of 10
relates. As such, under Rule 13d-3(a), Morken may be deemed to be the
beneficial owner of such shares.
Item 7. Identification and Classification of the Subsidiary Which Acquired the
Security Being Reported on the Parent Holding Company.
Not Applicable
Item 8. Identification and Classification of Members of the Group.
Not Applicable
Item 9. Notice of Dissolution of Group.
Not Applicable
Item 10. Certification.
By signing below, the undersigned certify that, to the best of its
knowledge and belief, the securities referred to above were not
acquired and are not held for the purpose of or with the effect of
changing or influencing the control of the issuer of the securities
and were not acquired and are not held in connection with or as a
participant in any transaction having such purpose or effect.
Page 7 of 10
Exhibits:
Exhibit I: Joint Filing Agreement, dated as of January 25, 2002, by and
among Advantage, Genesee and Morken.
Page 8 of 10
Exhibit I
JOINT FILING AGREEMENT
This will confirm the agreement by and among the undersigned that the
Schedule 13G filed with the Securities and Exchange Commission on or about the
date hereof with respect to the beneficial ownership of the undersigned of the
Common Shares, $.01 par value per share, of Cel Sci Corporation, a Colorado
corporation, is being filed, and all amendments thereto will be filed, on behalf
of each of the persons and entities named below in accordance with Rule 13d-1(k)
under the Securities Exchange Act of 1934, as amended. This Agreement may be
executed in two or more counterparts, each of which shall be deemed an original,
but all of which together shall constitute one and the same instrument.
Dated as of January 25, 2002.
ADVANTAGE FUND II LTD.
By: GENESEE INTERNATIONAL, INC.
As General Manager
/s/ Donald R. Morken
--------------------------
By: Donald R. Morken
Title: President
GENESEE INTERNATIONAL, INC.
/s/ Donald R. Morken
--------------------------
By: Donald R. Morken
Title: President
DONALD R. MORKEN
/s/ Donald R. Morken
--------------------------
Page 9 of 10
SIGNATURE
After reasonable inquiry and to the best of my knowledge and belief, I
certify that the information set forth in this statement is true, complete and
correct.
ADVANTAGE FUND II LTD.
By: GENESEE INTERNATIONAL, INC.
As General Manager
/s/ Donald R. Morken
--------------------------
By: Donald R. Morken
Title: President
GENESEE INTERNATIONAL, INC.
/s/ Donald R. Morken
--------------------------
By: Donald R. Morken
Title: President
DONALD R. MORKEN
By: /s/ Donald R. Morken
--------------------------
Page 10 of 10